6 TECH OUTLOOKDecember - 2020EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comEnrolling enough study subjects remains critical to the success of a clinical trial. With proper upfront planning playing a key role in today's competitive and complex research landscape, investing time in patient recruitment strategies can yield significant benefits. However, if a clinical research team fails to enroll enough patients into a clinical trial, by default it may extend the study timeline, increasing resource usage and costs. Besides, a prolonged study may delay a drug or treatment to reach the market, and thereafter, limit its availability for the general public after reaching the market. Thus, before designing a clinical trial, a clinical team must understand the complete regulatory requirements to conduct, complete, and produce quality clinical data. Various regulators have different needs, and these vary with the type of trial. Simultaneously, clinical research teams must allocate an adequate budget for advertising and partner with patient recruitment service providers. In this edition of Pharma Tech Outlook, we bring you the story of some of the most prominent organizations specializing in patient recruitment and are significant drivers of key trends and strategies. Besides, the magazine also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best patient recruitment consulting companies according to your requirements.Let us know your thoughts!Making Patient Recruitment the Heart of the Trial PlanningCopyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 02 - 2020, Vol 06 - Issue 28 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Scott JuasyTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >